Intermixed Normal Tissue within Prostate Cancer: Effect on MR Imaging Measurements of Apparent Diffusion Coefficient and T2—Sparse versus Dense Cancers-Reference-Cited by-同舟云学术

Intermixed Normal Tissue within Prostate Cancer: Effect on MR Imaging Measurements of Apparent Diffusion Coefficient and T2—Sparse versus Dense Cancers

Published:2008-12 Issue:3 Volume:249 Page:900-908
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Langer Deanna L.,van der Kwast Theodorus H.,Evans Andrew J.,Sun Laibao,Yaffe Martin J.,Trachtenberg John,Haider Masoom A.

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2493080236

Reference29 articles.

1. Focal Therapy for Localized Prostate Cancer: A Critical Appraisal of Rationale and Modalities

2. Active Surveillance for Prostate Cancer: For Whom?

3. Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer

4. Prostate Cancer: Localization with Three-dimensional Proton MR Spectroscopic Imaging—Clinicopathologic Study

5. SEXTANT LOCALIZATION OF PROSTATE CANCER: COMPARISON OF SEXTANT BIOPSY, MAGNETIC RESONANCE IMAGING AND MAGNETIC RESONANCE SPECTROSCOPIC IMAGING WITH STEP SECTION HISTOLOGY

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility and Reproducibility of T2 Mapping Compared with Diffusion-Weighted Imaging in Solid Renal Masses;Bioengineering;2024-09-07

2. The impact of benign tissue within cancerous regions in the prostate: Characterizing sparse and dense prostate cancers on whole-mount histopathology and on multiparametric MRI;Magnetic Resonance Imaging;2024-09

3. Apparent Diffusion Coefficient and Biopsy in Detecting Cribriform and Intraductal Carcinoma Prostate Cancer;Radiology;2024-07-01

4. Target Volume Optimization for Localized Prostate Cancer;Practical Radiation Oncology;2024-07

5. The value of apparent diffusion coefficient values in predicting Gleason grading of low to intermediate-risk prostate cancer;Insights into Imaging;2024-06-09